Loading…

Conditioned Medium From Azurin-Expressing Human Mesenchymal Stromal Cells Demonstrates Antitumor Activity Against Breast and Lung Cancer Cell Lines

Recently, cell-based therapies have been explored as a strategy to enhance the specificity of anticancer therapeutic agents. In this perspective, human mesenchymal stromal cells (MSC) hold a promising future as cell delivery systems for anticancer proteins due to their unique biological features. In...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in cell and developmental biology 2020-07, Vol.8, p.471-471
Main Authors: Silva, Marília, Monteiro, Gabriel Amaro, Fialho, Arsenio M., Bernardes, Nuno, da Silva, Cláudia Lobato
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c439t-bf392800997214ee5059ab4c4afc9ac6ba2e957e3f605ec621b7d8bf160b2fb43
cites cdi_FETCH-LOGICAL-c439t-bf392800997214ee5059ab4c4afc9ac6ba2e957e3f605ec621b7d8bf160b2fb43
container_end_page 471
container_issue
container_start_page 471
container_title Frontiers in cell and developmental biology
container_volume 8
creator Silva, Marília
Monteiro, Gabriel Amaro
Fialho, Arsenio M.
Bernardes, Nuno
da Silva, Cláudia Lobato
description Recently, cell-based therapies have been explored as a strategy to enhance the specificity of anticancer therapeutic agents. In this perspective, human mesenchymal stromal cells (MSC) hold a promising future as cell delivery systems for anticancer proteins due to their unique biological features. In this study, we engineered human MSC to secrete a human codon-optimized version of azurin (hazu), a bacterial protein that has demonstrated anticancer activity toward different cancer models both in vitro and in vivo . To this end, microporation was used to deliver plasmid DNA encoding azurin into MSC derived from bone marrow (BM) and umbilical cord matrix (UCM), leading to expression and secretion of hazu to the conditioned medium (CM). Engineered hazu-MSC were shown to preserve tumor tropism toward breast (MCF-7) and lung (A549) cancer cell lines, comparable to non-modified MSC. Azurin was detected in the CM of transfected MSC and, upon treatment with hazu-MSC-CM, we observed a decrease in cancer cell proliferation, migration, and invasion, and an increase in cell death for both cancer cell lines. Moreover, expression of azurin caused no changes in MSC expression profile of cytokines relevant in the context of cancer progression, thus suggesting that the antitumoral effects induced by hazu-MSC secretome might be due to the presence of azurin independently. In conclusion, data shown herein indicate that MSC-produced azurin in a CM configuration elicits an anticancer effect.
doi_str_mv 10.3389/fcell.2020.00471
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_8438a5c8ddb44c5595bc0e331720c28f</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_8438a5c8ddb44c5595bc0e331720c28f</doaj_id><sourcerecordid>2429780889</sourcerecordid><originalsourceid>FETCH-LOGICAL-c439t-bf392800997214ee5059ab4c4afc9ac6ba2e957e3f605ec621b7d8bf160b2fb43</originalsourceid><addsrcrecordid>eNpVks1u1DAUhSMEolXpnqWXbDI4_ontDVIYWlppEAtAYmc5zs3UVWIPtlN1eA1eGM9MhejqWD5Hn6-uT1W9bfCKUqnejxamaUUwwSuMmWheVOeEqLZuKfv58r_zWXWZ0j3GuCFccElfV2eUiIIQ7Xn1Zx384LILHgb0BQa3zOg6hhl1v5fofH31uIuQkvNbdLPMxpdMAm_v9rOZ0LdckkXXZZCEPsEcfMrRZEio89nlZQ4RdTa7B5f3qNsaV3z0MYIpYvyANkvhro23EI8QtHEe0pvq1WimBJdPelH9uL76vr6pN18_3667TW0ZVbnuR6qIxFgpQRoGwDFXpmeWmdEqY9veEFBcAB1bzMG2pOnFIPuxaXFPxp7Ri-r2xB2Cude76GYT9zoYp48XIW61idnZCbRkVBpu5TD0jFnOFe8tBkobQbAlciysDyfWbulnGCz4sojpGfS5492d3oYHLWhLhcAF8O4JEMOvBVLWs0uHHzYewpI0YUQJiaVUJYpPURtDShHGf880WB-qoY_V0Idq6GM16F93469G</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2429780889</pqid></control><display><type>article</type><title>Conditioned Medium From Azurin-Expressing Human Mesenchymal Stromal Cells Demonstrates Antitumor Activity Against Breast and Lung Cancer Cell Lines</title><source>PubMed Central Free</source><creator>Silva, Marília ; Monteiro, Gabriel Amaro ; Fialho, Arsenio M. ; Bernardes, Nuno ; da Silva, Cláudia Lobato</creator><creatorcontrib>Silva, Marília ; Monteiro, Gabriel Amaro ; Fialho, Arsenio M. ; Bernardes, Nuno ; da Silva, Cláudia Lobato</creatorcontrib><description>Recently, cell-based therapies have been explored as a strategy to enhance the specificity of anticancer therapeutic agents. In this perspective, human mesenchymal stromal cells (MSC) hold a promising future as cell delivery systems for anticancer proteins due to their unique biological features. In this study, we engineered human MSC to secrete a human codon-optimized version of azurin (hazu), a bacterial protein that has demonstrated anticancer activity toward different cancer models both in vitro and in vivo . To this end, microporation was used to deliver plasmid DNA encoding azurin into MSC derived from bone marrow (BM) and umbilical cord matrix (UCM), leading to expression and secretion of hazu to the conditioned medium (CM). Engineered hazu-MSC were shown to preserve tumor tropism toward breast (MCF-7) and lung (A549) cancer cell lines, comparable to non-modified MSC. Azurin was detected in the CM of transfected MSC and, upon treatment with hazu-MSC-CM, we observed a decrease in cancer cell proliferation, migration, and invasion, and an increase in cell death for both cancer cell lines. Moreover, expression of azurin caused no changes in MSC expression profile of cytokines relevant in the context of cancer progression, thus suggesting that the antitumoral effects induced by hazu-MSC secretome might be due to the presence of azurin independently. In conclusion, data shown herein indicate that MSC-produced azurin in a CM configuration elicits an anticancer effect.</description><identifier>ISSN: 2296-634X</identifier><identifier>EISSN: 2296-634X</identifier><identifier>DOI: 10.3389/fcell.2020.00471</identifier><identifier>PMID: 32733876</identifier><language>eng</language><publisher>Frontiers Media S.A</publisher><subject>azurin ; cancer ; Cell and Developmental Biology ; gene delivery ; mesenchymal stromal cells ; secretome</subject><ispartof>Frontiers in cell and developmental biology, 2020-07, Vol.8, p.471-471</ispartof><rights>Copyright © 2020 Silva, Monteiro, Fialho, Bernardes and da Silva. 2020 Silva, Monteiro, Fialho, Bernardes and da Silva</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c439t-bf392800997214ee5059ab4c4afc9ac6ba2e957e3f605ec621b7d8bf160b2fb43</citedby><cites>FETCH-LOGICAL-c439t-bf392800997214ee5059ab4c4afc9ac6ba2e957e3f605ec621b7d8bf160b2fb43</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7363770/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7363770/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids></links><search><creatorcontrib>Silva, Marília</creatorcontrib><creatorcontrib>Monteiro, Gabriel Amaro</creatorcontrib><creatorcontrib>Fialho, Arsenio M.</creatorcontrib><creatorcontrib>Bernardes, Nuno</creatorcontrib><creatorcontrib>da Silva, Cláudia Lobato</creatorcontrib><title>Conditioned Medium From Azurin-Expressing Human Mesenchymal Stromal Cells Demonstrates Antitumor Activity Against Breast and Lung Cancer Cell Lines</title><title>Frontiers in cell and developmental biology</title><description>Recently, cell-based therapies have been explored as a strategy to enhance the specificity of anticancer therapeutic agents. In this perspective, human mesenchymal stromal cells (MSC) hold a promising future as cell delivery systems for anticancer proteins due to their unique biological features. In this study, we engineered human MSC to secrete a human codon-optimized version of azurin (hazu), a bacterial protein that has demonstrated anticancer activity toward different cancer models both in vitro and in vivo . To this end, microporation was used to deliver plasmid DNA encoding azurin into MSC derived from bone marrow (BM) and umbilical cord matrix (UCM), leading to expression and secretion of hazu to the conditioned medium (CM). Engineered hazu-MSC were shown to preserve tumor tropism toward breast (MCF-7) and lung (A549) cancer cell lines, comparable to non-modified MSC. Azurin was detected in the CM of transfected MSC and, upon treatment with hazu-MSC-CM, we observed a decrease in cancer cell proliferation, migration, and invasion, and an increase in cell death for both cancer cell lines. Moreover, expression of azurin caused no changes in MSC expression profile of cytokines relevant in the context of cancer progression, thus suggesting that the antitumoral effects induced by hazu-MSC secretome might be due to the presence of azurin independently. In conclusion, data shown herein indicate that MSC-produced azurin in a CM configuration elicits an anticancer effect.</description><subject>azurin</subject><subject>cancer</subject><subject>Cell and Developmental Biology</subject><subject>gene delivery</subject><subject>mesenchymal stromal cells</subject><subject>secretome</subject><issn>2296-634X</issn><issn>2296-634X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNpVks1u1DAUhSMEolXpnqWXbDI4_ontDVIYWlppEAtAYmc5zs3UVWIPtlN1eA1eGM9MhejqWD5Hn6-uT1W9bfCKUqnejxamaUUwwSuMmWheVOeEqLZuKfv58r_zWXWZ0j3GuCFccElfV2eUiIIQ7Xn1Zx384LILHgb0BQa3zOg6hhl1v5fofH31uIuQkvNbdLPMxpdMAm_v9rOZ0LdckkXXZZCEPsEcfMrRZEio89nlZQ4RdTa7B5f3qNsaV3z0MYIpYvyANkvhro23EI8QtHEe0pvq1WimBJdPelH9uL76vr6pN18_3667TW0ZVbnuR6qIxFgpQRoGwDFXpmeWmdEqY9veEFBcAB1bzMG2pOnFIPuxaXFPxp7Ri-r2xB2Cude76GYT9zoYp48XIW61idnZCbRkVBpu5TD0jFnOFe8tBkobQbAlciysDyfWbulnGCz4sojpGfS5492d3oYHLWhLhcAF8O4JEMOvBVLWs0uHHzYewpI0YUQJiaVUJYpPURtDShHGf880WB-qoY_V0Idq6GM16F93469G</recordid><startdate>20200709</startdate><enddate>20200709</enddate><creator>Silva, Marília</creator><creator>Monteiro, Gabriel Amaro</creator><creator>Fialho, Arsenio M.</creator><creator>Bernardes, Nuno</creator><creator>da Silva, Cláudia Lobato</creator><general>Frontiers Media S.A</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20200709</creationdate><title>Conditioned Medium From Azurin-Expressing Human Mesenchymal Stromal Cells Demonstrates Antitumor Activity Against Breast and Lung Cancer Cell Lines</title><author>Silva, Marília ; Monteiro, Gabriel Amaro ; Fialho, Arsenio M. ; Bernardes, Nuno ; da Silva, Cláudia Lobato</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c439t-bf392800997214ee5059ab4c4afc9ac6ba2e957e3f605ec621b7d8bf160b2fb43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>azurin</topic><topic>cancer</topic><topic>Cell and Developmental Biology</topic><topic>gene delivery</topic><topic>mesenchymal stromal cells</topic><topic>secretome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Silva, Marília</creatorcontrib><creatorcontrib>Monteiro, Gabriel Amaro</creatorcontrib><creatorcontrib>Fialho, Arsenio M.</creatorcontrib><creatorcontrib>Bernardes, Nuno</creatorcontrib><creatorcontrib>da Silva, Cláudia Lobato</creatorcontrib><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Frontiers in cell and developmental biology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Silva, Marília</au><au>Monteiro, Gabriel Amaro</au><au>Fialho, Arsenio M.</au><au>Bernardes, Nuno</au><au>da Silva, Cláudia Lobato</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Conditioned Medium From Azurin-Expressing Human Mesenchymal Stromal Cells Demonstrates Antitumor Activity Against Breast and Lung Cancer Cell Lines</atitle><jtitle>Frontiers in cell and developmental biology</jtitle><date>2020-07-09</date><risdate>2020</risdate><volume>8</volume><spage>471</spage><epage>471</epage><pages>471-471</pages><issn>2296-634X</issn><eissn>2296-634X</eissn><abstract>Recently, cell-based therapies have been explored as a strategy to enhance the specificity of anticancer therapeutic agents. In this perspective, human mesenchymal stromal cells (MSC) hold a promising future as cell delivery systems for anticancer proteins due to their unique biological features. In this study, we engineered human MSC to secrete a human codon-optimized version of azurin (hazu), a bacterial protein that has demonstrated anticancer activity toward different cancer models both in vitro and in vivo . To this end, microporation was used to deliver plasmid DNA encoding azurin into MSC derived from bone marrow (BM) and umbilical cord matrix (UCM), leading to expression and secretion of hazu to the conditioned medium (CM). Engineered hazu-MSC were shown to preserve tumor tropism toward breast (MCF-7) and lung (A549) cancer cell lines, comparable to non-modified MSC. Azurin was detected in the CM of transfected MSC and, upon treatment with hazu-MSC-CM, we observed a decrease in cancer cell proliferation, migration, and invasion, and an increase in cell death for both cancer cell lines. Moreover, expression of azurin caused no changes in MSC expression profile of cytokines relevant in the context of cancer progression, thus suggesting that the antitumoral effects induced by hazu-MSC secretome might be due to the presence of azurin independently. In conclusion, data shown herein indicate that MSC-produced azurin in a CM configuration elicits an anticancer effect.</abstract><pub>Frontiers Media S.A</pub><pmid>32733876</pmid><doi>10.3389/fcell.2020.00471</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2296-634X
ispartof Frontiers in cell and developmental biology, 2020-07, Vol.8, p.471-471
issn 2296-634X
2296-634X
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_8438a5c8ddb44c5595bc0e331720c28f
source PubMed Central Free
subjects azurin
cancer
Cell and Developmental Biology
gene delivery
mesenchymal stromal cells
secretome
title Conditioned Medium From Azurin-Expressing Human Mesenchymal Stromal Cells Demonstrates Antitumor Activity Against Breast and Lung Cancer Cell Lines
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T12%3A12%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Conditioned%20Medium%20From%20Azurin-Expressing%20Human%20Mesenchymal%20Stromal%20Cells%20Demonstrates%20Antitumor%20Activity%20Against%20Breast%20and%20Lung%20Cancer%20Cell%20Lines&rft.jtitle=Frontiers%20in%20cell%20and%20developmental%20biology&rft.au=Silva,%20Mar%C3%ADlia&rft.date=2020-07-09&rft.volume=8&rft.spage=471&rft.epage=471&rft.pages=471-471&rft.issn=2296-634X&rft.eissn=2296-634X&rft_id=info:doi/10.3389/fcell.2020.00471&rft_dat=%3Cproquest_doaj_%3E2429780889%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c439t-bf392800997214ee5059ab4c4afc9ac6ba2e957e3f605ec621b7d8bf160b2fb43%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2429780889&rft_id=info:pmid/32733876&rfr_iscdi=true